Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Galantamine Effects on Nicotine Responses in Smokers

Phase 1

Completed

Conditions: Smoking
Tobacco Withdrawal

Interventions: Drug: IV Nicotine
Drug: Galantamine

First Posted Date: 2011-08-16

Last Posted Date: 2015-07-08

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT01417429

Locations: 🇺🇸
Department of Veterans Affairs, West Haven, Connecticut, United States

Emergency Department (ED) Disability Diagnostic Tool

Not Applicable

Completed

Conditions: Disability Diagnosis

Interventions: Other: RDDT

First Posted Date: 2011-08-15

Last Posted Date: 2014-07-09

Lead Sponsor: Yale University

Target Recruit Count: 635

Registration Number: NCT01416857

Locations: 🇺🇸
Yale New Haven Emergency Department, New Haven, Connecticut, United States
🇺🇸
Yale University, Emergency Department, New Haven, Connecticut, United States

Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment

Phase 2

Completed

Conditions: Cognitive Impairment
Substance Abuse
Substance Dependence

Interventions: Behavioral: Cognitive Training + Work Therapy
Behavioral: Work Therapy

First Posted Date: 2011-08-04

Last Posted Date: 2015-01-19

Lead Sponsor: Yale University

Target Recruit Count: 48

Registration Number: NCT01410110

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Not Applicable

Completed

Conditions: HIV
Liver Diseases, Alcoholic
Alcoholism
Hepatitis C

Interventions: Other: Treatment as Usual
Other: Integrated Stepped Care (ISC)

First Posted Date: 2011-08-04

Last Posted Date: 2022-12-21

Lead Sponsor: Yale University

Target Recruit Count: 319

Registration Number: NCT01410123

Locations: 🇺🇸
Washington DC VAMC, Washington, District of Columbia, United States
🇺🇸
VAMC Atlanta, Atlanta, Georgia, United States
🇺🇸
New York VAMC - New York Harbor Healthcare System, New York, New York, United States

and more 2 locations

Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study

Completed

Conditions: Unstable Angina
Acute Myocardial Infarction
Heart Attack
Acute Coronary Syndrome

First Posted Date: 2011-08-02

Last Posted Date: 2020-04-03

Lead Sponsor: Yale University

Target Recruit Count: 2381

Registration Number: NCT01407146

Locations: 🇺🇸
Yale University School of Nursing, New Haven, Connecticut, United States

Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery

Withdrawn

Conditions: Cardiac Surgery

Interventions: Device: Use of continuous glucose monitor during surgery. ( Medtronic Minimed Guardian REALTime Continuous Glucose Monitor)

First Posted Date: 2011-07-14

Last Posted Date: 2014-05-05

Lead Sponsor: Yale University

Registration Number: NCT01394588

Behavioral Drug and HIV Risk Reduction Counseling With MMT in China

Phase 3

Completed

Conditions: Opiate Dependence

Interventions: Behavioral: Treatment as Usual
Behavioral: Behavioral Drug and HIV Risk Reduction Counseling
Behavioral: Educational Counseling

First Posted Date: 2011-07-07

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 300

Registration Number: NCT01389180

Locations: 🇨🇳
Center for Disease Control & Prevention, Wuhan, Hubei, China

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

Phase 3

Completed

Conditions: Opiate Dependence

Interventions: Drug: Naltrexone (oral)
Drug: Vivitrol
Behavioral: Medical Management
Behavioral: BDRC

First Posted Date: 2011-07-07

Last Posted Date: 2018-01-11

Lead Sponsor: Yale University

Target Recruit Count: 320

Registration Number: NCT01389167

Locations: 🇷🇺
Pavlov University, St. Petersburg, Russian Federation

Fathers for Change for Men With Co-occurring Domestic Violence and Substance Abuse

Phase 1

Completed

Conditions: Domestic Violence
Substance Abuse
Parenting

Interventions: Behavioral: Individual Drug Counseling
Behavioral: Fathers for Change

First Posted Date: 2011-06-30

Last Posted Date: 2014-02-19

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT01385553

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

Phase 2

Completed

Conditions: Endometrial Cancer

Interventions: Drug: Carboplatin/Paclitaxel
Drug: Trastuzumab

First Posted Date: 2011-06-06

Last Posted Date: 2023-05-17

Lead Sponsor: Yale University

Target Recruit Count: 61

Registration Number: NCT01367002

Locations: 🇺🇸
Jersey Shore University Medical Center, Neptune, New Jersey, United States
🇺🇸
The Ohio State University, Hilliard, Ohio, United States
🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

and more 17 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy